AbbVie Inc. (ABBV)
NYSE: ABBV · Real-Time Price · USD
210.42
+0.63 (0.30%)
At close: Sep 9, 2025, 4:00 PM
210.39
-0.03 (-0.01%)
After-hours: Sep 9, 2025, 7:59 PM EDT
AbbVie Market Cap
AbbVie has a market cap or net worth of $371.72 billion as of September 9, 2025. Its market cap has increased by 7.08% in one year.
Market Cap
371.72B
Enterprise Value
435.84B
1-Year Change
7.08%
Ranking
Category
Stock Price
$210.42
Market Cap Chart
Since January 2, 2013, AbbVie's market cap has increased from $55.49B to $371.72B, an increase of 569.89%. That is a compound annual growth rate of 16.17%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 8, 2025 | 370.61B | 18.02% |
Dec 31, 2024 | 314.02B | 14.77% |
Dec 29, 2023 | 273.61B | -4.27% |
Dec 30, 2022 | 285.80B | 19.40% |
Dec 31, 2021 | 239.37B | 26.54% |
Dec 31, 2020 | 189.17B | 44.48% |
Dec 31, 2019 | 130.93B | -5.58% |
Dec 31, 2018 | 138.67B | -10.18% |
Dec 29, 2017 | 154.39B | 51.71% |
Dec 30, 2016 | 101.76B | 5.08% |
Dec 31, 2015 | 96.84B | -7.12% |
Dec 31, 2014 | 104.26B | 24.10% |
Dec 31, 2013 | 84.01B | 51.40% |
Jan 2, 2013 | 55.49B | - |
View and export this data all the way back to 2013. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 663.10B |
Johnson & Johnson | 429.00B |
UnitedHealth Group | 290.04B |
AstraZeneca | 251.37B |
Novartis AG | 249.66B |
Novo Nordisk | 242.52B |
Abbott Laboratories | 230.09B |
Merck & Co. | 210.04B |